Evidence map›Paper›PMID 32863012›Full record

GuidelineRehabilitacion

[Management of patients with lymphatic diseases and lipoedema during the COVID-19 pandemic. Recommendations of the Spanish Group of Lymphology].

I Forner Cordero, M López Martin, L Reina Gutiérrez, R Belmonte, R Ruiz Miñarro, M P Crespo Cobo, B Pardo Sievers, V Pujol Blaya, C De Miguel Benadiba, C Puigdellivol

Open access · greenAbstract readConsensus StatementPractice GuidelineReview
In one paragraph

Guideline in Rehabilitacion. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 9 institutions in 1 country.

I Forner CorderoUnidad de Linfedema, Servicio de Medicina Física y Rehabilitación, Hospital Universitari i Politècnic La Fe, Universitat de Valencia, Valencia, España. Electronic address: Forner_isa@gva.es.
M López MartinUnidad de Linfedema, Servicio Rehabilitación y Medicina Física, Hospital Universitario de la Princesa, Madrid, España.
L Reina GutiérrezServicio de Angiología y Cirugía Vascular, Hospital Central de la Cruz Roja, Madrid, España.
R BelmonteMedicina Física i Rehabilitació Parc de Salut Mar, Barcelona, Universitat Autònoma de Barcelona, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona, España.
R Ruiz MiñarroUnidad de Linfedema, Clínica Salut i Esport, Barcelona, España.
M P Crespo CoboUnidad de Linfedema, Hospital Universitario Gregorio Marañón, Madrid, España.
B Pardo SieversServicio de Fisioterapia, Hospital Clínico Universitario de Valencia, Valencia, España.
V Pujol BlayaHospital Universitario Vall d'Hebron, Universitat Autònoma de Barcelona, Bellaterra, Barcelona, España.
C De Miguel BenadibaHospital Ramón y Cajal, Universidad Alcalá de Henares, Madrid, España.
C PuigdellivolUnidad de Flebología y Linfología. Instituto Cardiovascular Teknon. Hospital Quiron -Teknon, Barcelona, España.
Hospital Central de la Cruz Roja San José y Santa Adela · ESHospital Clínico Universitario de Valencia · ESHospital del Mar Research Institute · ESHospital General Universitario Gregorio Marañón · ESHospital Quirón Teknon · ESHospital Universitario de La Princesa · ESUniversidad de Alcalá · ESUniversitat Autònoma de Barcelona · ESUniversitat de València · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The COVID-19 pandemic poses a challenge to the management of non-COVID pathologies such as lymphatic diseases and lipoedema. The use of telemedicine can prevent the spread of the disease. A system is needed to help determine the clinical priority and selection of face-to-face or telemedicine options for each patient and how to carry them out during the pandemic. The Spanish Lymphology Group has drafted a consensus document with recommendations based on the literature and clinical experience, as clinical practice guidelines for the management of lymphatic abnormalities and lipoedema during the COVID-19 pandemic. These recommendations must be adapted to the characteristics of each patient, the local conditions of the centres, and the decisions of health care professionals. The document contains minimum criteria, subject to modifications according to the evolution of the pandemic, scientific knowledge and instructions from health authorities.

Indexed as

BetacoronavirusCoronavirus InfectionsPandemicsPneumonia, ViralTelemedicineComorbidityCompression BandagesContinuity of Patient CareCOVID-19Disease ManagementEmergenciesEquipment DesignHealth Services Needs and DemandHumansLipedemaLymphatic DiseasesAnomalía linfáticaAnomalía vascularAnomalía venosaCOVID-19LinfedemaLipedemaLipoedemaLymphatic anomaliesLymphoedemaMalformación vascularPandemiaPandemicSARS-CoV-2TelemedicinaTelemedicineTriageTriajeVascularVascular anomaliesVascular malformationVenous anomalies

Identifiers

PMID32863012
PMCPMC7414319
OpenAlexW3047797980

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.